Alex Biese

Citing toxicities and lack of efficacy, some are calling for caution when treating older patients with melanoma with immune checkpoint inhibitors.

A second dendritic cell vaccine has received fast track designation from the Food and Drug Administration.

Nubeqa plus androgen deprivation therapy displayed positive radiological progression-free survival results in early trial data.

For some patients with early non-small cell lung cancer and lung scarring, stereotactic ablative radiotherapy may be a viable option, research has shown.

One expert explains what patients with prostate cancer interested in clinical trial participation need to know.

A radiation oncology nurse explains the spectrum of side effects that can come with radiation for prostate cancer.

One radiation oncologist describes the advantages of MRI-guided SBRT when treating patients with prostate cancer.

While adherence to germline testing has been found to be low, one expert explained why tests findings could matter to patients.

As part of our “Speaking Out” video series, we look at the association between prostate cancer and mental health.

Updated data has been reported evaluating efti and Keytruda in PD-L1 negative recurrent or metastatic head and neck squamous cell carcinoma.

One expert from the University of Colorado Cancer Center explains the multidisciplinary aspect of sarcoma care to maximize patients’ functioning.

Patients with favorable-risk prostate cancer “should be aware that they don't need treatment right away,” one expert said.

The TIL therapy OBX-115 ‘may have the potential to address’ an unmet need among patients with metastatic or locally advanced melanoma.

Perioperative treatment with BRAF and MEK inhibitors was found to benefit some patients with stage 3 and 4 melanoma, according to a recent study.

One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma.

Patients with TGCT are encouraged to honestly discuss their pain with their care teams.

One expert explains the importance of a multidisciplinary care team for patients with TGCT.

TGCT is a non-malignant tumor, but one expert explained how it can similarly affect patients.

Tenosynovial giant cell tumors are not malignant but can impact patients’ quality of life, as one expert explained.

Systemic therapy and active surveillance can be viable options for patients with TGCT, as one expert explained.

Treatment with the CAR-T cell therapy Carvykti has been reported to improve survival among some patients with multiple myeloma.

The Food and Drug Administration recently approved Augtyro for the treatment of patients ages 12 and older with solid tumors harboring an NTRK gene fusion.

Following promising European trial results, a new peptide vaccine for melanoma is being studied in America, with results expected next year.

The Food and Drug Administration issued six approvals for solid tumors in June, including thyroid, endometrial, colorectal, breast and ovarian cancers.

One specialist explained the ways palliative care, also known as supportive care, can assist patients during a breast cancer journey.

Patients saw improved event-free survival and overall survival with presurgical Imfinzi and chemotherapy followed by surgery and postsurgical Imfinzi.

One expert explained the common side effects at every line of treatment for metastatic HER2-positive breast cancer during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

A Biologics License Application has been filed for the subcutaneous administration of Rybrevant for some patients with non-small cell lung cancer.

One expert explains why “the future of precision medicine” has arrived in lung cancer at the CURE® Educated Patient® Lung Cancer Summit.

LGBTQI+ patients with cancer are encouraged to seek positive relationships with care teams despite possible histories of minority stress.